OneThree Biotech

OneThree Biotech is a clinically validated, biology-driven artificial intelligence (AI) company focused on using its proprietary AI platform in combination with systems biology to understand the mechanisms that drive drug-target-disease relationships. OneThree Biotech's proven technology platform integrates chemical, biological, and clinical data with cutting-edge computational tools to answer complex questions surrounding disease biology and drug discovery. The company's AI platform has shown success in optimizing early-stage drug discovery and development by quickly and accurately generating new, testable insights and hypotheses. The OneThree platform has been validated across early stage drug discovery through multiple partnerships, clinical trials, and over 20 peer reviewed publications.